Prothena: Q4 Earnings Snapshot

In this article:

DUBLIN (AP) — DUBLIN (AP) — Prothena Corp. (PRTA) on Thursday reported a loss of $67.5 million in its fourth quarter.

On a per-share basis, the Dublin-based company said it had a loss of $1.26.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.23 per share.

The drug developer posted revenue of $316,000 in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $1.1 million.

For the year, the company reported a loss of $147 million, or $2.76 per share. Revenue was reported as $91.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTA at https://www.zacks.com/ap/PRTA

Advertisement